Abstract: Described herein are compounds that are useful as protein kinase inhibitors having the formula:
where R1, R2, T and Ht are described in the specification. The compounds are useful for treating disease states in mammals that are alleviated by a protein kinase inhibitor, particularly diseases such as cancer, inflammatory disorders, restenosis, and cardiovascular disease.
Type:
Grant
Filed:
October 5, 2001
Date of Patent:
August 31, 2004
Assignee:
Vertex Pharmaceuticals Incorporated
Inventors:
Michael Hale, James Janetka, Francois Maltais, Jingrong Cao